Last updated: 3 September 2020 at 5:08pm EST

David Ghesquiere Net Worth




The estimated Net Worth of David W. Ghesquiere is at least $1.67 Million dollars as of 16 March 2020. Mr. Ghesquiere owns over 3,177 units of Nanostring Technologies Inc stock worth over $7,537 and over the last 11 years he sold NSTG stock worth over $204,517. In addition, he makes $1,455,550 as Senior Vice President - Corporate and Business Development at Nanostring Technologies Inc.

Mr. Ghesquiere NSTG stock SEC Form 4 insiders trading

David has made over 11 trades of the Nanostring Technologies Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 3,177 units of NSTG stock worth $335 on 16 March 2020.

The largest trade he's ever made was exercising 22,000 units of Nanostring Technologies Inc stock on 27 February 2020 worth over $275,000. On average, David trades about 2,811 units every 40 days since 2013. As of 16 March 2020 he still owns at least 71,577 units of Nanostring Technologies Inc stock.

You can see the complete history of Mr. Ghesquiere stock trades at the bottom of the page.





David Ghesquiere biography

David W. Ghesquiere serves as Senior Vice President - Corporate and Business Development of the Company. Prior to joining our company, Mr. Ghesquiere was the founder and managing director of Adrenaline Venture & Advisory LLC, an international advisory firm, from August 2012 to November 2013. Prior to founding Adrenaline Venture & Advisory, Mr. Ghesquiere served as Senior Vice President, Corporate & Business Development at Dendreon Corporation, a biotechnology company, from 2011 to 2012. From 2005 to 2010, Mr. Ghesquiere held a variety of executive positions at OSI Pharmaceuticals, acquired by Astellas Pharma in 2010, including Senior Vice-President of Corporate & Business Development and Managing Director of OSI Investment Holdings GmbH and OSI Investment Management GmbH, OSI’s wholly owned, Switzerland-based subsidiaries, where he played a key role in establishing OSI’s venture capital arm. Earlier in his career, Mr. Ghesquiere served as Director of Global Business Development for Aventis Pharmaceuticals, which merged with Sanofi in 2004, and worked in product marketing at Johnson & Johnson. Mr. Ghesquiere received an M.B.A. from The University of Western Ontario’s Ivey School of Business and a B.A. in economics from The University of Western Ontario.

What is the salary of David Ghesquiere?

As the Senior Vice President - Corporate and Business Development of Nanostring Technologies Inc, the total compensation of David Ghesquiere at Nanostring Technologies Inc is $1,455,550. There are 4 executives at Nanostring Technologies Inc getting paid more, with R. Bradley Gray having the highest compensation of $7,288,840.



How old is David Ghesquiere?

David Ghesquiere is 53, he's been the Senior Vice President - Corporate and Business Development of Nanostring Technologies Inc since 2013. There are 13 older and 4 younger executives at Nanostring Technologies Inc. The oldest executive at Nanostring Technologies Inc is William Young, 75, who is the Independent Chairman of the Board.

What's David Ghesquiere's mailing address?

David's mailing address filed with the SEC is 530 Fairview Ave N, Seattle, WA 98109, USA.

Insiders trading at Nanostring Technologies Inc

Over the last 11 years, insiders at Nanostring Technologies Inc have traded over $114,083,977 worth of Nanostring Technologies Inc stock and bought 981,722 units worth $9,126,410 . The most active insiders traders include Charles P Jr Waite, Lifesciences Ii, L.P.Clarus..., and Nicholas Galakatos. On average, Nanostring Technologies Inc executives and independent directors trade stock every 16 days with the average trade being worth of $4,371. The most recent stock trade was executed by Joseph M Beechem on 6 May 2024, trading 147,853 units of NSTG stock currently worth $15,569.



What does Nanostring Technologies Inc do?

nanostring technologies (nasdaq: nstg) is a publicly held provider of life science tools for translational research and molecular diagnostics. the company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. nanostring technologies provides life science tools for translational research and molecular diagnostic products. the company's ncounter® analysis system, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 300 peer-reviewed publications, has also now been applied to diagnostic use as the ncounter dx analysis system. the company's technology offers a cost-effective way to easily profile the expression of hundreds of genes, mirnas, or copy number variations, simultaneously with high sensitivity and precision. the company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and vali



What does Nanostring Technologies Inc's logo look like?

Nanostring Technologies Inc logo

Complete history of Mr. Ghesquiere stock trades at Nanostring Technologies Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
16 Mar 2020 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 3,177 $19.53 $62,047
16 Mar 2020
71,577
11 Mar 2020 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 18,039 $30.50 $550,190
11 Mar 2020
74,187
9 Mar 2020 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 3,334 $31.39 $104,654
9 Mar 2020
57,908
27 Feb 2020 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 22,000 $12.50 $275,000
27 Feb 2020
76,169
9 Jan 2020 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 19,579 $12.50 $244,738
9 Jan 2020
73,448
11 Nov 2019 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 2,500 $23.19 $57,975
11 Nov 2019
54,786
19 Aug 2019 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 18,421 $19.36 $356,631
19 Aug 2019
70,243
5 Jun 2019 David W. Ghesquiere
SVP, Corporate, and Business Dev
Sale 6,954 $29.41 $204,517
5 Jun 2019
44,868
12 Nov 2018 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 2,500 $15.27 $38,175
12 Nov 2018
31,657
13 Nov 2017 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 2,500 $8.14 $20,350
13 Nov 2017
17,327
1 Mar 2016 David W. Ghesquiere
SVP, Corporate, and Business Dev
Option 5,000 $14.30 $71,500
1 Mar 2016
7,521


Nanostring Technologies Inc executives and stock owners

Nanostring Technologies Inc executives and other stock owners filed with the SEC include: